Ponatinib | Market Exclusivity | US | Dates | PharmaCompass.com

Please Wait

Applying Filters...

Find Suppliers : API/FDF
- Search Our Integrated Database
Services
Excipients
NEW Find Prospects
- Prospector
Drugs in Dev.
News
Blog
Market Place
Login

Ponatinib
US Exclusivities

AbbVie CDMO has been working with global companies to develop, manufacture & scale biopharmaceutical products.

Contact Supplier

European CDMO and Gx manufacturer with 75 years of experience in delivering premium APIs to pharmaceutical partners worldwide.

Contact Supplier

pharmacompass-1-m-2026-01-12

Evonik Health Care is the innovation hub for leading life science companies

Contact Supplier

EUROAPI, the leading small molecules API player, provides both API sales & CDMO services.

Contact Supplier

pharmacompass-2-2026-02-09

Ponatinib

ACCESS ALL DATA, CHEMISTRY

ACCESS ALL DATA
CHEMISTRY
Discover Molecule Insights

ACTIVE PHARMA INGREDIENTS

14 API Suppliers, 3 USDMF, 3 EU WC, 1 KDMF, 4 NDC API, 9 Listed Suppliers, $ API Reference Price

14 API Suppliers
3 USDMF
3 EU WC
1 KDMF
4 NDC API
9 Listed Suppliers
$ API Reference Price

DEVELOPMENTS

26 Drugs in Development

26 Drugs in Development

INTERMEDIATES

6 Intermediate Suppliers

6 Intermediate Suppliers

FINISHED DOSAGE FORMULATIONS

36 FDF Dossiers, 6 FDA Orange Book, 23 Europe, 1 Canada, 6 Australia

36 FDF Dossiers
6 FDA Orange Book
23 Europe
1 Canada
6 Australia

DRUG PRODUCT COMPOSITIONS

TABLET;ORAL - EQ 10MG BASE, TABLET;ORAL - EQ 15MG BASE, TABLET;ORAL - EQ 30MG BASE, TABLET;ORAL - EQ 45MG BASE

TABLET;ORAL - EQ 10MG BASE
TABLET;ORAL - EQ 15MG BASE
TABLET;ORAL - EQ 30MG BASE
TABLET;ORAL - EQ 45MG BASE

RELATED EXCIPIENT COMPANIES

1 SPI Pharma, 3 Gangwal Healthcare, 1 Nanjing Well Pharmaceutical, 3 Anhui Sunhere Pharmaceutical Excipients Co.,Ltd, 4 DFE Pharma, 4 Gangwal Chemicals, 1 Ideal Cures, 10 Kerry, 1 Keval Exports, 9 Microlex e.U, 2 Nitika Pharmaceutical Specialities, 1 Pharmatrans-Sanaq, 2 Pluviaendo, 2 Prachin Chemical, 7 Roquette, 2 Shanghai Shenmei Pharmaceutical Technology Co., Ltd, 8 Sigachi Industries, 2 Silverline Chemicals, 2 Vasa Pharmachem

1 SPI Pharma
3 Gangwal Healthcare
1 Nanjing Well Pharmaceutical
3 Anhui Sunhere Pharmaceutical Excipients Co.,Ltd
4 DFE Pharma
4 Gangwal Chemicals
1 Ideal Cures
10 Kerry
1 Keval Exports
9 Microlex e.U
2 Nitika Pharmaceutical Specialities
1 Pharmatrans-Sanaq
2 Pluviaendo
2 Prachin Chemical
7 Roquette
2 Shanghai Shenmei Pharmaceutical Technology Co., Ltd
8 Sigachi Industries
2 Silverline Chemicals
2 Vasa Pharmachem

EXCIPIENTS BY APPLICATIONS

27 Fillers, Diluents & Binders, 12 Direct Compression, 11 Granulation, 10 Lubricants & Glidants, 9 Thickeners and Stabilizers, 8 Co-Processed Excipients, 4 Disintegrants & Superdisintegrants, 3 Chewable & Orodispersible Aids, 3 Controlled & Modified Release, 2 Emulsifying Agents, 2 Coating Systems & Additives, 2 Taste Masking, 1 Parenteral, 1 Film Formers & Plasticizers, 1 API Stability Enhancers, 1 Rheology Modifiers

27 Fillers, Diluents & Binders
12 Direct Compression
11 Granulation
10 Lubricants & Glidants
9 Thickeners and Stabilizers
8 Co-Processed Excipients
4 Disintegrants & Superdisintegrants
3 Chewable & Orodispersible Aids
3 Controlled & Modified Release
2 Emulsifying Agents
2 Coating Systems & Additives
2 Taste Masking
1 Parenteral
1 Film Formers & Plasticizers
1 API Stability Enhancers
1 Rheology Modifiers

DIGITAL CONTENT

1 Stock Recap #PipelineProspector, 39 News #PharmaBuzz

1 Stock Recap #PipelineProspector
39 News #PharmaBuzz

GLOBAL SALES INFORMATION

1 US Medicaid Prescriptions, 2 Regulatory FDF Prices, 10 Annual Reports

1 US Medicaid Prescriptions
2 Regulatory FDF Prices
10 Annual Reports

MARKET PLACE

5 APIs, 2 FDF Dossiers

5 APIs
2 FDF Dossiers

PATENTS & EXCLUSIVITIES

68 US Patents, 8 US Exclusivities, 4 Health Canada Patents

68 US Patents
8 US Exclusivities
4 Health Canada Patents

$ API Ref.Price (USD/KG) : 84,358 Xls

Filters

Reset all filters

Filters

FILTER :

filter Company Name Reset all filters

8 All

01 8TAKEDA PHARMS USA

filter Product Reset all filters

8 All

01 8PONATINIB HYDROCHLORIDE

filter Exclusivity Expiration Date Reset all filters

8 All

01 42027-03-19

02 42031-03-19

filter Exclusivity Code Reset all filters

8 All

01 4I-934

02 4ODE-472

Product Main Page

TAKEDA PHARMS USA

Contact Supplier

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Post an Enquiry

Post an Enquiry

Digital Content

PONATINIB HYDROCHLORIDE

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

Exclusivity Code

ODE-472

Exclusivity Expiration Date

2031-03-19

Application Number

203469

Product Number

2

Exclusivity Details

01

TAKEDA PHARMS USA

PONATINIB HYDROCHLORIDE

International Sweetener Colloquium

Not Confirmed

TAKEDA PHARMS USA

Japan

International Sweetener Colloquium

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

PONATINIB HYDROCHLORIDE

Exclusivity Code : ODE-472

Exclusivity Expiration Date : 2031-03-19

Application Number : 203469

Product Number : 2

Exclusivity Details :

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

TAKEDA PHARMS USA

Contact Supplier

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Post an Enquiry

Post an Enquiry

Digital Content

PONATINIB HYDROCHLORIDE

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

Exclusivity Code

I-934

Exclusivity Expiration Date

2027-03-19

Application Number

203469

Product Number

2

Exclusivity Details

02

TAKEDA PHARMS USA

PONATINIB HYDROCHLORIDE

International Sweetener Colloquium

Not Confirmed

TAKEDA PHARMS USA

Japan

International Sweetener Colloquium

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

PONATINIB HYDROCHLORIDE

Exclusivity Code : I-934

Exclusivity Expiration Date : 2027-03-19

Application Number : 203469

Product Number : 2

Exclusivity Details :

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

TAKEDA PHARMS USA

Contact Supplier

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Post an Enquiry

Post an Enquiry

Digital Content

PONATINIB HYDROCHLORIDE

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

Exclusivity Code

ODE-472

Exclusivity Expiration Date

2031-03-19

Application Number

203469

Product Number

1

Exclusivity Details

03

TAKEDA PHARMS USA

PONATINIB HYDROCHLORIDE

International Sweetener Colloquium

Not Confirmed

TAKEDA PHARMS USA

Japan

International Sweetener Colloquium

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

PONATINIB HYDROCHLORIDE

Exclusivity Code : ODE-472

Exclusivity Expiration Date : 2031-03-19

Application Number : 203469

Product Number : 1

Exclusivity Details :

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

TAKEDA PHARMS USA

Contact Supplier

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Post an Enquiry

Post an Enquiry

Digital Content

PONATINIB HYDROCHLORIDE

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

Exclusivity Code

I-934

Exclusivity Expiration Date

2027-03-19

Application Number

203469

Product Number

1

Exclusivity Details

04

TAKEDA PHARMS USA

PONATINIB HYDROCHLORIDE

International Sweetener Colloquium

Not Confirmed

TAKEDA PHARMS USA

Japan

International Sweetener Colloquium

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

PONATINIB HYDROCHLORIDE

Exclusivity Code : I-934

Exclusivity Expiration Date : 2027-03-19

Application Number : 203469

Product Number : 1

Exclusivity Details :

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

TAKEDA PHARMS USA

Contact Supplier

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Post an Enquiry

Post an Enquiry

Digital Content

PONATINIB HYDROCHLORIDE

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

Exclusivity Code

ODE-472

Exclusivity Expiration Date

2031-03-19

Application Number

203469

Product Number

4

Exclusivity Details

05

TAKEDA PHARMS USA

PONATINIB HYDROCHLORIDE

International Sweetener Colloquium

Not Confirmed

TAKEDA PHARMS USA

Japan

International Sweetener Colloquium

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

PONATINIB HYDROCHLORIDE

Exclusivity Code : ODE-472

Exclusivity Expiration Date : 2031-03-19

Application Number : 203469

Product Number : 4

Exclusivity Details :

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

TAKEDA PHARMS USA

Contact Supplier

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Post an Enquiry

Post an Enquiry

Digital Content

PONATINIB HYDROCHLORIDE

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

Exclusivity Code

I-934

Exclusivity Expiration Date

2027-03-19

Application Number

203469

Product Number

4

Exclusivity Details

06

TAKEDA PHARMS USA

PONATINIB HYDROCHLORIDE

International Sweetener Colloquium

Not Confirmed

TAKEDA PHARMS USA

Japan

International Sweetener Colloquium

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

PONATINIB HYDROCHLORIDE

Exclusivity Code : I-934

Exclusivity Expiration Date : 2027-03-19

Application Number : 203469

Product Number : 4

Exclusivity Details :

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

TAKEDA PHARMS USA

Contact Supplier

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Post an Enquiry

Post an Enquiry

Digital Content

PONATINIB HYDROCHLORIDE

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

Exclusivity Code

ODE-472

Exclusivity Expiration Date

2031-03-19

Application Number

203469

Product Number

3

Exclusivity Details

07

TAKEDA PHARMS USA

PONATINIB HYDROCHLORIDE

International Sweetener Colloquium

Not Confirmed

TAKEDA PHARMS USA

Japan

International Sweetener Colloquium

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

PONATINIB HYDROCHLORIDE

Exclusivity Code : ODE-472

Exclusivity Expiration Date : 2031-03-19

Application Number : 203469

Product Number : 3

Exclusivity Details :

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

TAKEDA PHARMS USA

Contact Supplier

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Post an Enquiry

Post an Enquiry

Digital Content

PONATINIB HYDROCHLORIDE

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

Exclusivity Code

I-934

Exclusivity Expiration Date

2027-03-19

Application Number

203469

Product Number

3

Exclusivity Details

08

TAKEDA PHARMS USA

PONATINIB HYDROCHLORIDE

International Sweetener Colloquium

Not Confirmed

TAKEDA PHARMS USA

Japan

International Sweetener Colloquium

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

PONATINIB HYDROCHLORIDE

Exclusivity Code : I-934

Exclusivity Expiration Date : 2027-03-19

Application Number : 203469

Product Number : 3

Exclusivity Details :

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

Contact us
to update this info

Privacy policy
Terms and conditions
Disclaimers
Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.